You are here

  • Home
  • Online First
  • A multicentre, randomised, double-blind, placebo controlled phase II study of subcutaneously administered interferon beta 1a in the treatment of patients with active rheumatoid arthritis

Article Text

Article menu

other Versions

Download PDFPDF
Extended Report
A multicentre, randomised, double-blind, placebo controlled phase II study of subcutaneously administered interferon beta 1a in the treatment of patients with active rheumatoid arthritis

https://doi.org/10.1136/ard.2003.020347

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.